T-cell genetic modification for re-directed tumor recognition-Reference-Cited by-同舟云学术

T-cell genetic modification for re-directed tumor recognition

Published:2005 Issue: Volume: Page:293-324
ISSN:0921-4410
Container-title:Cancer Chemotherapy and Biological Response Modifiers Annual
language:
Short-container-title:

Author:

Cooper Laurence J.N.,Kalos Michael,DiGiusto David,Brown Christine,Forman Stephen J.,Raubitschek Andrew,Jensen Michael C.

Publisher

Elsevier

Reference207 articles.

1. Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation;Sullivan;Prog Clin Biol Res,1987

2. Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation;Fefer;Prog Clin Biol Res,1987

3. Identical-twin bone marrow transplants for leukemia;Gale;Ann Intern Med,1994

4. New directions in allogeneic stem cell transplantation;Barrett;Semin Hematol,2002

5. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation;Childs;N Engl J Med,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Universal CARs, universal T cells, and universal CAR T cells;Journal of Hematology & Oncology;2018-11-27

2. IL-13 receptor-directed cancer vaccines and immunotherapy;Immunotherapy;2012-04

3. A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells;Blood;2011-08-04

4. Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor;Blood;2010-08-19

5. IL-13 receptor-α2: a novel target for cancer therapy;Immunotherapy;2009-05